UPDATE: Oppenheimer Maintains Outperform Rating, Raises PT for Thoratec


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


In a quarterly update released earlier today, Oppenheimer & Co. Inc. maintained its Outperform rating for Thoratec Corporation (NASDAQ: THOR) and raised its price target from $40.00 to $42.00.Oppenheimer said its decision “is predicated on our belief that the Left Ventricular Assist Device (LVAD) market is one of the big growth opportunities in medtech. THOR will be the only company with an indication for the larger destination therapy segment of the US market for the next three years. We estimate the market will grow at a high-teens five-year CAGR from sub $400M in 2010 to $1B by 2015.”Thoratec Corporation closed yesterday at $34.50.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetReiterationAnalyst RatingsOppenheimer & Co. Inc.